Karyopharm Therapeutics Inc. - Common Stock (KPTI)

6.9950
+0.6750 (10.68%)
NASDAQ · Last Trade: Apr 7th, 2:13 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026